{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:16:10Z","timestamp":1791918970586,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.intimp.2023.109783","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T12:36:49Z","timestamp":1675946209000},"page":"109783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["MARCO is a potential prognostic and immunotherapy biomarker"],"prefix":"10.1016","volume":"116","author":[{"given":"Qingyu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3624-6390","authenticated-orcid":false,"given":"Guihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3522-3971","authenticated-orcid":false,"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.109783_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103374","article-title":"TMB or not TMB as a biomarker: That is the question","volume":"163","author":"Addeo","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.intimp.2023.109783_b0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.04.004","article-title":"DNA mismatch repair in cancer","volume":"189","author":"Baretti","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.109783_b0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109783_b0020","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4049\/jimmunol.171.2.924","article-title":"Identification of uteroglobin-related protein 1 and macrophage scavenger receptor with collagenous structure as a lung-specific ligand-receptor pair","volume":"171","author":"Bin","year":"2003","journal-title":"J. Immunol."},{"issue":"14\u201315","key":"10.1016\/j.intimp.2023.109783_b0025","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.micinf.2007.09.002","article-title":"Macrophage receptors implicated in the \u201cadaptive\u201d form of innate immunity","volume":"9","author":"Bowdish","year":"2007","journal-title":"Microbes Infect."},{"issue":"11","key":"10.1016\/j.intimp.2023.109783_b0030","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2023.109783_b0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"20","key":"10.1016\/j.intimp.2023.109783_b0040","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1056\/NEJMc1508163","article-title":"Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma","volume":"373","author":"Chan","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.109783_b0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13073-021-00906-x","article-title":"Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker","volume":"13","author":"Chen","year":"2021","journal-title":"Genome Med."},{"key":"10.1016\/j.intimp.2023.109783_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114354","article-title":"Targeting tumor-associated macrophages as an antitumor strategy","volume":"183","author":"Cheng","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"50","key":"10.1016\/j.intimp.2023.109783_b0055","doi-asserted-by":"crossref","first-page":"32005","DOI":"10.1073\/pnas.2015343117","article-title":"Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells","volume":"117","author":"Eisinger","year":"2020","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.intimp.2023.109783_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091129","article-title":"MARCO(+) Macrophage Dynamics in Regenerating Liver after 70% Liver Resection in Mice","volume":"9","author":"Elchaninov","year":"2021","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.intimp.2023.109783_b0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"269","key":"10.1016\/j.intimp.2023.109783_b0070","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"9","key":"10.1016\/j.intimp.2023.109783_b0075","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","article-title":"Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis","volume":"15","author":"Georgoudaki","year":"2016","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.intimp.2023.109783_b0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109783_b0085","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.7150\/thno.50928","article-title":"Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2023.109783_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.534761","article-title":"Tumor-Associated CD68(+), CD163(+), and MARCO(+) Macrophages as Prognostic Biomarkers in Patients With Treatment-Naive Gastroesophageal Adenocarcinoma","volume":"10","author":"Jeremiasen","year":"2020","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2023.109783_b0095","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.109783_b0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.it.2021.02.006","article-title":"Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines","volume":"42","author":"Kang","year":"2021","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109783_b0105","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/pj.2016.37","article-title":"Low-dielectric-constant polyimide aerogel composite films with low water uptake","volume":"48","author":"Kim","year":"2016","journal-title":"Polym. J."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2023.109783_b0110","doi-asserted-by":"crossref","first-page":"e000511","DOI":"10.1136\/esmoopen-2019-000511","article-title":"How I treat MSI cancers with advanced disease","volume":"4","author":"Kok","year":"2019","journal-title":"ESMO Open"},{"issue":"4","key":"10.1016\/j.intimp.2023.109783_b0115","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1158\/0008-5472.CAN-20-1885","article-title":"Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function","volume":"81","author":"La Fleur","year":"2021","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.intimp.2023.109783_b0120","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.31545","article-title":"Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer","volume":"143","author":"La Fleur","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2023.109783_b0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-016-4013-7","article-title":"miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients","volume":"160","author":"Lanczky","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.intimp.2023.109783_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.566511","article-title":"Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers","volume":"10","author":"Larionova","year":"2020","journal-title":"Front. Oncol."},{"issue":"W1","key":"10.1016\/j.intimp.2023.109783_b0135","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.intimp.2023.109783_b0140","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.2805","article-title":"Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer","volume":"4","author":"Li","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.intimp.2023.109783_b0145","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3389\/fimmu.2020.02039","article-title":"Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109783_b0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.matbio.2017.12.009","article-title":"Thrombospondin-1 regulation of latent TGF-beta activation: A therapeutic target for fibrotic disease","volume":"68\u201369","author":"Murphy-Ullrich","year":"2018","journal-title":"Matrix Biol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109783_b0155","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109783_b0160","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","article-title":"Neoantigen vaccine: an emerging tumor immunotherapy","volume":"18","author":"Peng","year":"2019","journal-title":"Mol. Cancer"},{"issue":"13","key":"10.1016\/j.intimp.2023.109783_b0165","doi-asserted-by":"crossref","first-page":"i555","DOI":"10.1093\/bioinformatics\/bty271","article-title":"GSEA-InContext: identifying novel and common patterns in expression experiments","volume":"34","author":"Powers","year":"2018","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.intimp.2023.109783_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030558","article-title":"PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer","volume":"13","author":"Rizzo","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2023.109783_b0175","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13059-020-02140-x","article-title":"Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma","volume":"21","author":"Sa","year":"2020","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109783_b0180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.intimp.2023.109783_b0185","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1002\/ijc.33115","article-title":"Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors","volume":"147","author":"Salem","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2023.109783_b0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ebiom.2018.12.054","article-title":"Development and validation of an immune gene-set based Prognostic signature in ovarian cancer","volume":"40","author":"Shen","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2023.109783_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.771488","article-title":"The Scavenger Receptor MARCO Expressed by Tumor-Associated Macrophages Are Highly Associated With Poor Pancreatic Cancer Prognosis","volume":"11","author":"Shi","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.intimp.2023.109783_b0200","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jtho.2020.05.019","article-title":"The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee","volume":"15","author":"Sholl","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2023.109783_b0205","article-title":"Macrophage Receptor with Collagenous Structure (MARCO) Is Processed by either Macropinocytosis or Endocytosis-Autophagy Pathway","volume":"10","author":"Srinivasula","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.intimp.2023.109783_b0210","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/jgh.13633","article-title":"Association of decreased expression of the macrophage scavenger receptor MARCO with tumor progression and poor prognosis in human hepatocellular carcinoma","volume":"32","author":"Sun","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"W1","key":"10.1016\/j.intimp.2023.109783_b0215","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.intimp.2023.109783_b0220","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.intimp.2023.109783_b0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","article-title":"Microsatellite instability in colorectal cancer-the stable evidence","volume":"7","author":"Vilar","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2023.109783_b0230","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1007\/s12035-021-02463-1","article-title":"TLR2 Potentiates SR-Marco-Mediated Neuroinflammation by Interacting with the SRCR Domain","volume":"58","author":"Wang","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109783_b0235","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/bib\/bbaa026","article-title":"Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer","volume":"22","author":"Wang","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"2","key":"10.1016\/j.intimp.2023.109783_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111542","article-title":"Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma","volume":"383","author":"Xiao","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.109783_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112862","article-title":"Scavenger receptor MARCO contributes to macrophage phagocytosis and clearance of tumor cells","volume":"408","author":"Xing","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2023.109783_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.605097","article-title":"An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment","volume":"10","author":"Xu","year":"2020","journal-title":"Front. Oncol."},{"issue":"20","key":"10.1016\/j.intimp.2023.109783_b0255","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1158\/0008-5472.CAN-20-0069","article-title":"Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma","volume":"80","author":"Zheng","year":"2020","journal-title":"Cancer Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923001066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923001066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T08:21:23Z","timestamp":1719217283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923001066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":51,"alternative-id":["S1567576923001066"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109783","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MARCO is a potential prognostic and immunotherapy biomarker","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109783"}}